Details for New Drug Application (NDA): 063099
✉ Email this page to a colleague
NDA 063099 describes TRIMOX, which is a drug marketed by Apothecon and is included in eight NDAs. Additional details are available on the TRIMOX profile page.
The generic ingredient in TRIMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
The generic ingredient in TRIMOX is amoxicillin. There are forty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the amoxicillin profile page.
Summary for 063099
| Tradename: | TRIMOX |
| Applicant: | Apothecon |
| Ingredient: | amoxicillin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063099
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Mar 20, 1992 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 500MG | ||||
| Approval Date: | Mar 20, 1992 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
